Increasing prion propensity by hydrophobic insertion

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Gonzalez Nelson, Aaron C ^a   Paul, Kacy R ^a   Petri, Michelina ^a   Flores, Noe ^a   Rogge, Ryan A ^a   Cascarina, Sean M ^a   Ross, Eric D ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ASPARAGINE; GLUTAMINE; PRION PROTEIN; TYROSINE; PRION; SACCHAROMYCES CEREVISIAE PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HYDROPHOBIC INSERTION; HYDROPHOBICITY; IN VITRO STUDY; NONHUMAN; PRION; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; VIROGENESIS; YEAST; BIOLOGY; CHEMICAL PHENOMENA; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTAGENESIS; MUTATION; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; AMYLOID; ASPARAGINE; BLOTTING, WESTERN; COMPUTATIONAL BIOLOGY; GLUTAMINE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; PRIONS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TYROSINE;

EID: 84895887574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089286     Document Type: Article

References (69)

1. Wadsworth JD, Collinge J (2007) Update on human prion disease. Biochim Biophys Acta 1772: 598-609. (Pubitemid 46887654)
2. Coustou V, Deleu C, Saupe S, Begueret J (1997) The protein product of the hets heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 94: 9773-9778. (Pubitemid 27408139)
3. Maclea KS, Ross ED (2011) Strategies for identifying new prions in yeast. Prion 5: 263-268.
4. Li YR, King OD, Shorter J, Gitler AD (2013) Stress granules as crucibles of ALS pathogenesis. J Cell Biol 201: 361-372.
5. Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21: 904-919.
6. Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ (2009) Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol 256: 1205-1214.
7. Weihl CC, Temiz P, Miller SE, Watts G, Smith C, et al. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79: 1186-1189.
8. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, et al. (2012) Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet: Epub ahead of print.
9. Couthouis J, Hart MP, Shorter J, Dejesus-Hernandez M, Erion R, et al. (2011) A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A 108: 20881-20890.
10. Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, et al. (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134: 2595-2609.
11. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495: 467-473.
12. Klar J, Sobol M, Melberg A, Mabert K, Ameur A, et al. (2013) Welander distal myopathy caused by an ancient founder mutation in TIA1 associated with perturbed splicing. Hum Mutat 34: 572-577.
13. Bradley ME, Liebman SW (2004) The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions. Mol Microbiol 51: 1649-1659. (Pubitemid 38406539)
14. Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137: 671-676. (Pubitemid 24196460)
15. Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, et al. (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7: 683-692. (Pubitemid 23090350)
16. Harrison PM, Gerstein M (2003) A method to assess compositional bias in biological sequences and its application to prion-like glutamine/asparagine-rich domains in eukaryotic proteomes. Genome Biol 4: R40.
17. Liu JJ, Sondheimer N, Lindquist SL (2002) Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99 Suppl 4: 16446-16453. (Pubitemid 35470992)
18. Ross ED, Baxa U, Wickner RB (2004) Scrambled Prion Domains Form Prions and Amyloid. Mol Cell Biol 24: 7206-7213. (Pubitemid 39014446)
19. Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins. Cell 137: 146-158.
20. Michelitsch MD, Weissman JS (2000) A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. Proc Natl Acad Sci USA 97: 11910-11915.
21. Sondheimer N, Lindquist S (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5: 163-172. (Pubitemid 30105445)
22. Halfmann R, Wright J, Alberti S, Lindquist S, Rexach M (2012) Prion formation by a yeast GLFG nucleoporin. Prion 6.
23. Ross ED, Toombs JA (2010) The effects of amino acid composition on yeast prion formation and prion domain interactions. Prion 4: 60-65.
24. Toombs JA, McCarty BR, Ross ED (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30: 319-332.
25. Ross ED, Maclea KS, Anderson C, Ben-Hur A (2013) A bioinformatics method for identifying Q/N-rich prion-like domains in proteins. Methods Mol Biol 1017: 219-228.
26. Toombs JA, Petri M, Paul KR, Kan GY, Ben-Hur A, et al. (2012) De novo design of synthetic prion domains. Proc Natl Acad Sci U S A 109: 6519-6524.
27. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424: 805-808. (Pubitemid 37021713)
28. Maurer-Stroh S, Debulpaep M, Kuemmerer N, Lopez de la Paz M, Martins IC, et al. (2010) Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nature Methods 7: 237-242.
29. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, et al. (2008) Prediction of aggregation-prone regions in structured proteins. J Mol Biol 380: 425-436.
30. Goldschmidt L, Teng PK, Riek R, Eisenberg D (2010) Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 107: 3487-3492.
31. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol 22: 1302-1306. (Pubitemid 39336784)
32. Salnikova AB, Kryndushkin DS, Smirnov VN, Kushnirov VV, Ter-Avanesyan MD (2005) Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids. J Biol Chem 280: 8808-8812. (Pubitemid 40409569)
33. Alexandrov AI, Polyanskaya AB, Serpionov GV, Ter-Avanesyan MD, Kushnirov VV (2012) The effects of amino acid composition of glutaminerich domains on amyloid formation and fragmentation. PLoS ONE 7: e46458.
34. Toombs JA, Liss NM, Cobble KR, Ben-Musa Z, Ross ED (2011) [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain. PLoS One 6: e21953.
35. Sherman F (1991) Getting started with yeast. Methods Enzymol 194: 3-21.
36. Song Y, Wu YX, Jung G, Tutar Y, Eisenberg E, et al. (2005) Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication. Eukaryot Cell 4: 289-297. (Pubitemid 40257129)
37. Ross ED, Edskes HK, Terry MJ, Wickner RB (2005) Primary sequence independence for prion formation. Proc Natl Acad Sci USA 102: 12825-12830. (Pubitemid 41279450)
38. Gietz RD, Sugino A (1988) New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74: 527-534. (Pubitemid 19060666)
39. Cormack BP, Bertram G, Egerton M, Gow NA, Falkow S, et al. (1997) Yeast-enhanced green fluorescent protein (yEGFP)a reporter of gene expression in Candida albicans. Microbiology 143: 303-311. (Pubitemid 27092165)
40. Ross CD, McCarty BM, Hamilton M, Ben-Hur A, Ross ED (2009) A promiscuous prion: Efficient induction of [URE3] prion formation by heterologous prion domains. Genetics 183: 929-940.
41. Bagriantsev SN, Kushnirov VV, Liebman SW (2006) Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol 412: 33-48. (Pubitemid 44548572)
42. Collins SR, Douglass A, Vale RD, Weissman JS (2004) Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition. PLoS Biology 2: e321.
43. Alexandrov IM, Vishnevskaya AB, Ter-Avanesyan MD, Kushnirov VV (2008) Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation. J Biol Chem 283: 15185-15192.
44. Osherovich LZ, Cox BS, Tuite MF, Weissman JS (2004) Dissection and design of yeast prions. PLoS Biol 2: E86.
45. DePace AH, Santoso A, Hillner P, Weissman JS (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93: 1241-1252. (Pubitemid 28307428)
46. Parham SN, Resende CG, Tuite MF (2001) Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions. EMBO J 20: 2111-2119. (Pubitemid 32410581)
47. Shkundina IS, Kushnirov VV, Tuite MF, Ter-Avanesyan MD (2006) The role of the N-terminal oligopeptide repeats of the yeast sup35 prion protein in propagation and transmission of prion variants. Genetics 172: 827-835. (Pubitemid 43345421)
48. Cox BS (1965) PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 26: 211-232.
49. Lancaster AK, Bardill JP, True HL, Masel J (2010) The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] system. Genetics 184: 393-400.
50. Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566-569.
51. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997) Genetic and Environmental Factors Affecting the de novo Appearance of the [PSI(+)] Prion in Saccharomyces cerevisiae. Genetics 147: 507-519. (Pubitemid 27418562)
52. Ferreira PC, Ness F, Edwards SR, Cox BS, Tuite MF (2001) The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation. Mol Microbiol 40: 1357-1369. (Pubitemid 32635304)
53. Jung G, Masison DC (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast prions. Curr Microbiol 43: 7-10. (Pubitemid 32549917)
54. Ness F, Ferreira P, Cox BS, Tuite MF (2002) Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22: 5593-5605. (Pubitemid 34755768)
55. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15: 3127-3134. (Pubitemid 26187760)
56. Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YO (2001) Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 21: 4656-4669. (Pubitemid 32588248)
57. LeVine H 3rd (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309: 274-284.
58. Chen B, Bruce KL, Newnam GP, Gyoneva S, Romanyuk AV, et al. (2010) Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 76: 1483-1499.
59. Santoso A, Chien P, Osherovich LZ, Weissman JS (2000) Molecular basis of a yeast prion species barrier. Cell 100: 277-288. (Pubitemid 30064915)
60. Tessier PM, Lindquist S (2007) Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447: 556-561. Epub 2007 May 2009.
61. Pastor MT, Esteras-Chopo A, Serrano L (2007) Hacking the code of amyloid formation: the amyloid stretch hypothesis. Prion 1: 9-14. Epub 2007 Jan 2005.
62. Lopez de la Paz M, Serrano L (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A 101: 87-92. Epub 2003 Dec 2022.
63. Thompson MJ, Sievers SA, Karanicolas J, Ivanova MI, Baker D, et al. (2006) The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci U S A 103: 4074-4078.
64. Teng PK, Eisenberg D (2009) Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel 22: 531-536.
65. McGlinchey RP, Kryndushkin D, Wickner RB (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci U S A 108: 5337-5341.
66. Ohhashi Y, Ito K, Toyama BH, Weissman JS, Tanaka M (2010) Differences in prion strain conformations result from non-native interactions in a nucleus. Nature 6: 225-230.
67. Street AG, Mayo SL (1999) Intrinsic beta-sheet propensities result from van der Waals interactions between side chains and the local backbone. Proc Natl Acad Sci U S A 96: 9074-9076. (Pubitemid 29374709)
68. Espinosa Angarica V, Ventura S, Sancho J (2013) Discovering putative prion sequences in complete proteomes using probabilistic representations of Q/N-rich domains. BMC Genomics 14: 316.
69. Crow ET, Du Z, Li L (2011) A small, glutamine-free domain propagates the [SWI(+)] prion in budding yeast. Mol Cell Biol 31: 3436-3444.